Claudia Tenney (R-NY)

PILLS Act

H.R. 1396 · House bill Taxation

A Republican bill with 2 Republican cosponsors · See all 2 cosponsors

Last activity — Referred to the House Committee on Ways and Means.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the "PILLS Act," aims to amend the Internal Revenue Code of 1986 to encourage the domestic production of generic drugs and biosimilars. It establishes a production credit for taxpayers producing eligible components within the United States and selling them to unrelated persons. Additionally, it creates an investment credit for taxpayers establishing qualified facilities for the production of these components. The production credit includes provisions for increased percentages for certain products and bonuses for domestic content. The bill also includes a phase-out schedule for the production credit starting after 2030.

Yes· 3 of 8

  • Scored +5

    Would business owners be better off under this?

    The bill provides significant tax credits for pharmaceutical manufacturers and facility investors.

  • Scored +4

    Is this likely to create jobs?

    The production and investment credits are intended to incentivize the establishment of domestic manufacturing facilities.

  • Scored +3

    Is this likely to grow the economy?

    By subsidizing domestic pharmaceutical manufacturing, the bill aims to stimulate industrial activity in the US.

The opposite

  • Scored -2

    Does this make trade with other countries easier?

    The bill focuses on domesticating supply chains by specifically excluding foreign entities of concern from receiving credits.